Human cytomegalovirus (CMV) could practically be a tale of two pathogens. Among healthy adults, CMV infections are quite common and largely asymptomatic. Indeed, by age 40, at...

Since becoming commercially available over the last 10–15 years, liquid biopsies have been enthusiastically embraced, particularly for noninvasive prenatal screening and increasingly...

Single test on BD MAX Molecular Diagnostic System identifies and differentiates multiple respiratory infectious diseases.

Despite global focus on the COVID-19 pandemic, the concern around antimicrobial resistance (AMR) has continued to grow, albeit a bit further in the background. In 2019, AMR was...

A new molecular diagnostic system to expand access to PCR testing in the U.S.

The 2022 Medical Laboratory Observer (MLO) State of the Industry (SOI) survey on molecular diagnostics revealed some intriguing insights on the use of molecular testing by U.S...

Rising demand for point-of-care diagnostics augurs well for sector.

In clinical study on asymptomatic people, Cue demonstrated 99.4% accuracy compared to lab-based PCR.

Have you ever wanted to either implement or expand the use of liquid chromatography – tandem mass spectrometry (LC-MS/MS) in your clinical lab but have put off doing so because...

BD (Becton, Dickinson and Company) announced the outcome of a peer-reviewed study published in Obstetrics & Gynecology, showing that molecular diagnostics could improve the accuracy...